This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Chronic dacrocyocystitis

Authoring team

This is infection of the lacrimal sac. It is usually unilateral and secondary to obstruction of the nasolacrimal duct at the entrance to the nose. It is most common in infants or in persons over 40 years of age, especially post-menopausal women.

Acute dacryocystitis usually results from infection by staphylococcus aureus or less frequently, beta hemolytic streptococcus. In chronic dacryocystitis, streptococcus pneumoniae, or more rarely, Candida albicans may be the causative organism.

Uncommonly, the condition follows obstruction of the nasolacrimal duct by Actinomyces israelii (streptothrix) (1). Actinomyces israelii is a cast-forming Gram-positive anaerobe that is difficult to isolate and identify.

Presentation is with epiphora, swelling and redness at the inner canthus of the eye. In the chronic form, a mucocoele is often formed.

Conjunctivitis develops rarely. A corneal ulcer may develop following minor corneal trauma in the presence of pneumococcal dacryocystitis.

Antibiotics such as penicillin are often effective. A mucocoele suggests obstruction in the nasolacrimal duct and requires dacryocystorhinostomy (a procedure to establish communication between the nasal cavity and the lacrimal sac).

Reference:

  1. Aust N Z J Ophthalmol. 1997 Nov;25(4):301-3

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.